Schedule your Pfizer COVID-19 vaccine Monday through Thursday from 8 a.m. - 5 p.m. and Friday from 8 a.m. - noon.  Learn more >

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Investigator: Polly Niravath, MD

Study Coordinator: Latasha Senegal

Status: Enrolling

ClinicalTrials.gov Number: NCT01984138

Phone: 713.441.1159

Protocol Number: Pro00017710

Description

This study is investigating whether breast cancer patients who experience vaginal dryness while on anti-estrogen treatment could benefit from either vaginal estrogen or from a vaginal moisturizer called Replens.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials